Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors.

Swislocki AL, Jialal I.

Metab Syndr Relat Disord. 2015 Sep;13(7):287-91. doi: 10.1089/met.2015.1504. Epub 2015 Apr 20.

PMID:
25893855
2.

Pharmacotherapy for the metabolic syndrome.

Swislocki AL, Siegel D, Jialal I.

Curr Vasc Pharmacol. 2012 Mar;10(2):187-205. Review.

PMID:
22022773
3.

Long-term maintenance of glucose control in veterans with type 2 diabetes mellitus using oral agents.

Swislocki AL, Meier JL, Najera SM, Noth RH.

Metab Syndr Relat Disord. 2011 Dec;9(6):469-73. doi: 10.1089/met.2011.0038. Epub 2011 Aug 24.

PMID:
21864034
4.

Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database.

Garcia EA, Lopez JR, Meier JL, Swislocki AL, Siegel D.

J Clin Hypertens (Greenwich). 2011 Jul;13(7):487-91. doi: 10.1111/j.1751-7176.2011.00443.x. Epub 2011 Mar 28.

PMID:
21762361
5.

The ACCORD Study: the devil is in the details.

Siegel D, Swislocki AL.

Metab Syndr Relat Disord. 2011 Apr;9(2):81-4. doi: 10.1089/met.2010.0119. Epub 2010 Dec 18.

PMID:
21166575
6.

Hypertensive treatment in patients with metabolic syndrome.

Siegel D, Swislocki AL.

Metab Syndr Relat Disord. 2010 Apr;8(2):95-104. doi: 10.1089/met.2009.0086. Review.

PMID:
20156078
7.

The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended-release niacin.

Libby A, Meier J, Lopez J, Swislocki AL, Siegel D.

Metab Syndr Relat Disord. 2010 Feb;8(1):79-84. doi: 10.1089/met.2009.0074.

PMID:
19943800
8.

Computer-based screening of veterans for metabolic syndrome.

Keane J, Meier JL, Noth RH, Swislocki AL.

Metab Syndr Relat Disord. 2009 Dec;7(6):557-61. doi: 10.1089/met.2009.0021.

PMID:
19558266
9.

Smokeless nicotine exposure has no lasting effect on fasting or postglucose circulation leptin in young rats.

Swislocki AL, Fakiri Z.

Metab Syndr Relat Disord. 2008 Dec;6(4):257-62. doi: 10.1089/met.2008.0017.

PMID:
19067528
10.

Effects of antihypertensives on glucose metabolism.

Siegel D, Swislocki AL.

Metab Syndr Relat Disord. 2007 Sep;5(3):211-9. doi: 10.1089/met.2007.0016.

PMID:
18370775
11.

The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients.

Siegel D, Meier J, Maas C, Lopez J, Swislocki AL.

Am J Hypertens. 2008 Apr;21(4):438-42. doi: 10.1038/ajh.2007.75. Epub 2008 Jan 31.

PMID:
18246056
12.

The stumble-from pipe cleaner to bone builder.

Swislocki AL, Wexler JA.

Endocr Pract. 2007 Mar-Apr;13(2):194-7. Review.

PMID:
17490936
13.

Adoption of a new technology in a Veterans Affairs national formulary system with local implementation: the insulin glargine example.

Barengolts EI, Burke BV, Duckworth WC, Kaminsky R, Miller DR, Swislocki AL.

Manag Care Interface. 2007 Mar;20(3):37-44, 57.

PMID:
17458480
15.

Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control.

Meier JL, Swislocki AL, Lopez JR, Noth RH, Bartlebaugh P, Siegel D.

Am J Manag Care. 2002 Jun;8(6):557-65.

16.

Voluntary running improves glucose tolerance and insulin resistance in female spontaneously hypertensive rats.

LaPier TL, Swislocki AL, Clark RJ, Rodnick KJ.

Am J Hypertens. 2001 Jul;14(7 Pt 1):708-15.

PMID:
11465658
17.
18.

Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats.

Swislocki AL, LaPier TL, Khuu DT, Fann KY, Tait M, Rodnick KJ.

Am J Hypertens. 1999 Jun;12(6):581-9.

PMID:
10371367
19.

Safety and efficacy of metformin in a restricted formulary.

Swislocki AL, Khuu Q, Liao E, Wu E, Beza F, Lopez J, Kwan G, Noth RH.

Am J Manag Care. 1999 Jan;5(1):62-8.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk